S. O. Kachula

S. O. Kachula

Auto-generated profile, based on publicly available information

S. O. Kachula

National Pirogov Memorial Medical University, Vinnytsya, Ukraine

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
14 March 2024 in Reports of Vinnytsia National Medical University
Verified
Journal Article
Open access
PDF file
PYP. O. Yurchenko
P. O. Yurchenko
VSV. M. Shkarupa
V. M. Shkarupa
OKO. Y. Kakarkin
O. Y. Kakarkin
AKA. P. Kovalchuk
A. P. Kovalchuk
BKB. А. Kovalchuk
B. А. Kovalchuk
SKS. O. Kachula
S. O. Kachula
Annotation. Tamoxifen belongs to the group of selective estrogen receptor modulators (SERM) and is metabolized by the detoxification system of xenobiotics, and the phenomenon of metabolic activation can be observed at the first stage. CYP2D6 also directly participates in this process, the analysis of polymorphic forms of which can influence the prediction of the effectiveness and toxicity of tamoxifen in the treatment of luminal forms of breast cancer, which is of great importance considering the duration of therapy with this drug. The aim – to analyze scientific literature data on the effect of CYP2D6 and its polymorphs on the metabolism of tamoxifen in the treatment of luminal forms of breast cancer. A retrospective analysis of the literature of scientific databases Scopus, Web of Science, PubMed., MedLines for 2013-2023 was carried out. It is established that CYP2D6 can be considered a predictor of treatment effectiveness only in patients with breast cancer (ER+) who are postmenopausal and receive 20 mg of tamoxifen per day for 5 years and do not have hepatotoxic conditions and CYP2D6 inhibition phenomena, which determines the expediency of genotyping CYP2D6 polymorphic variants in such a group. Long-term therapy with tamoxifen can be complicated by the development of secondary endometrial cancer. Undesirable effects of tamoxifen may also depend on the activity of CYP2D6. Thus, in slow metabolizers, for example, carriers of CYP2D6*3/*4 and CYP2D6*6/*6, a statistically significant increase in the frequency of cases of endometrial hyperplasia was observed. In addition, polymorphisms of other enzymes of the biotransformation system of xenobiotics that participate in both the activation and deactivation of tamoxifen and its metabolites, both the first (CYP3A4, CYP3A5, CYP2B6, CYP2C9, CYP2C19 and CYP2D6) and the second phase (SULT and UGT), remain a promising direction for study. The study of the consequences of the phenomena of iatrogenic cholestasis and drug interactions at the level of CYP2D6, which may affect the metabolism of tamoxifen, also requires a detailed study, taking into account the intensive pharmacotherapy of BC. Анотація. Тамоксифен відноситься до групи селективних модуляторів естрогенових рецепторів (SERM) і метаболізується системою детоксикації ксенобіотиків причому на першій ії стадії може спостерігається явище метаболічної активації. В цьому процесі безпосередньо приймає участь і CYP2D6, аналіз поліморфних форм якого може вплинути на прогноз ефективності та токсичності тамоксифену при лікуванні люмінальних форм раку молочної залози (РМЗ), що має велике значення, враховуючи термін терапії цим препаратом. Мета – проаналізувати дані наукової літератури щодо вивчення впливу CYP2D6 та його поліморфних форм на метаболізм тамоксифену при терапії люмінальних форм раку молочної залози. Проведений ретроспективний аналіз літератури наукових баз Scopus, Web of Science, PubMed., MedLines за 2013-2023 роки. Встановлено, що CYP2D6 можна вважати предиктором ефективності лікування тільки у пацієнток з РМЗ (ER+), які знаходяться в постменопаузі та отримують 20 мг тамоксифена в день 5 років і не мають гепатотоксичних станів і явищ інгібування CYP2D6, що обумовлює доцільність генотипування поліморфних варіантів CYP2D6 саме в такій групі. Тривала терапія тамоксифеном маже ускладнитися розвитком вторинного раку ендометрія. Небажані ефекти тамоксифена можуть залежати в тому числі й від активності CYP2D6. Так у повільних метаболізаторів, наприклад носіїв CYP2D6*3/*4 та CYP2D6*6/*6 спостерігалося статистично значуще збільшення частоти випадків гіперплазії ендометрія. Крім того, перспективним напрямком для вивчення залишаються поліморфізми інших ферментів системи біотрансформації ксенобіотиків, що приймають участь як в активації, так і деактивації тамоксифена та його метаболітів як першої (CYP3A4, CYP3A5, CYP2B6, CYP2C9, CYP2C19 та CYP2D6), так і другої (SULT та UGT) фази. Дослідження наслідків явищ ятрогенного холестазу та взаємодій лікарських засобів на рівні CYP2D6, що можуть впливати на метаболізм тамоксифену також потребує детального дослідження, враховуючи інтенсивну фармакотерапію РМЗ.

7 December 2023 in Reports of Vinnytsia National Medical University
Verified
Journal Article
Open access
PDF file
PYP. O. Yurchenko
P. O. Yurchenko
VSV. M. Shkarupa
V. M. Shkarupa
SKS. O. Kachula
S. O. Kachula
OKO. Y. Kakarkin
O. Y. Kakarkin
AKA. P. Kovalchuk
A. P. Kovalchuk
DFD. O. Filchukov
D. O. Filchukov
Annotation. Tamoxifen (TAM) (1-[4-(2-dimethylaminoethoxy)-phenyl]-1,2-diphenylbut-1(Z)-ene) is a non-steroidal selective estrogen receptor modulator (SERM), which is recognized as the "gold standard" of hormone therapy for estrogen-dependent breast cancer (BC). It is known that adjuvant treatment with TAM increases recurrence-free survival and overall survival in patients with hormone-receptor-positive breast cancer. Also, tamoxifen manifests itself as a partial estrogen agonist, which can be associated with the development of complications such as endometrial cancer, venous thromboembolism, etc. The presence of resistance and relapses during TAM therapy, which reach up to 30%, remains an actual problem. Therefore, studying the mechanisms underlying the individualization of both therapeutic effect and toxicity associated with TAM remains an important challenge. In the detoxification of both TAM and its active metabolites, glucuronidation processes, which belong to the second phase of biotransformation of xenobiotics and actively take place in the liver as well as in the mammary gland, play an important role, and therefore the study of this process can contribute to the understanding of the interindividual variability of the therapeutic effect and toxicity of TAM. The aim – to analyze the data of the scientific literature on the study of the influence of glucuronyltransferase (UGT) enzymes and their polymorphic forms on the biotransformation of TAM and its active metabolites in the treatment of hormone-receptor-positive breast cancer. A retrospective analysis of the literature of scientific databases Scopus, Web of Science, PubMed., MedLines for 2013-2023 was carried out. It is possible to draw the following conclusions that UGT isozymes are responsible for the conjugation and detoxification of tamoxifen and its metabolites in the form of glucuronides 4-OH-tamoxifen-N-glucuronide, 4-OH-tamoxifen-O-glucuronide and endoxifen-O-glucuronide. UGT1A8, UGT1A10, UGT2B7, UGT2B15 and UGT2B17 isoforms played the greatest role in glucuronidation of tamoxifen and its active metabolites, but UGT1A4 was recognized as the main one. Depending on the content of active TAM metabolites and their glucuronides in the blood plasma, it can be stated that carriers of the UGT2B15 Lys523Thr and UGT2B17del alleles demonstrated increased enzyme activity, and individuals with one variant UGT2B15 523Thr allele can even be considered superactive metabolizers of 4-OH-tamoxifen-O- glucuronide and endoxifen-glucuronide. Also, high levels of 4-OH-tamoxifen-N-glucuronide were observed in carriers of the allele of the UGT2B17del genotype. Carriers of the above alleles have high activity of glucuronidation processes and low levels of active metabolites of TAM, which calls into question the rationality of prescribing TAM as hormone therapy. In contrast, patients with UGT1A4 48Val, UGT2B7 268Tyr alleles, or with wild-type genotypes for UGT2B17 nodel and UGT2B15 523Lys, will have high levels of active metabolites and are the group of choice for tamoxifen therapy in estrogen-receptor-positive breast cancer because they will have a low rate of glucuronidation and detoxification. However, in order to create a system of clinical algorithms for the formation of tamoxifen-sensitive groups of patients, further detailed study of other possibilities of the biotransformation system in the metabolism of tamoxifen is required.

28 June 2024 in Reports of Vinnytsia National Medical University
Verified
Journal Article
Open access
PDF file
NAN. Aleksyeyenko
N. Aleksyeyenko
VAV. Andriichuk
V. Andriichuk
RRR. Radoha
R. Radoha
VDV. Danylevych
V. Danylevych
SKS. Kachula
S. Kachula
Annotation. Reforms and the integration of our Country into European standards led to changes in medical control and provision of conditions for obtaining education and emphasized the importance of preserving the health of students, one of the monitoring methods of which is control over indicators of physical development. The purpose of our study is to determine changes in the component composition of body weight during 2 academic years in rural and urban residents under the education. We used J. Matiegka’s formulas for the research. We determined the component composition of body mass in 200 practically healthy men (100 residents of the village, 100 residents of the city) in the 1st, 2nd and 3rd years of study at the Higher Professional School of Civil Defense of the Lviv University of Life Safety (Vinnytsia). Statistical processing of the obtained results was carried out in the package “STATISTICA 6.1” using parametric and non-parametric methods of evaluating the obtained results. Analysing the obtained results, it can be concluded that at the beginning of the study, there was no significant difference in the indicators of the component composition of the body mass of young men from the village and the city, although the bone and fat indicators of the components were higher in the residents of the village, and the muscle component was higher in the city dwellers. During education, the indicators of muscle and bone components increased in both groups of young men, and the increase prevailed in the first year of training; the indicator of the fat component decreased during the education of rural and urban youth, mainly in the first year. The intergroup annual change of all indicators of the component composition of body weight in the first year of education of the village residents were greater compared to the city residents’ ones, and the indicator of the annual fat component change had significant differences. In the second year of study, the intergroup annual change of all indicators of the component composition of body weight was again greater among the residents of the village, but there were no significant differences.

28 December 2025 in UKRAINIAN JOURNAL HEALTH OF WOMAN
Verified
Journal Article
Closed access
MKM.I. Kravtsiv
M.I. Kravtsiv
KBK.I. Bohadelnikova
K.I. Bohadelnikova
KCK.V. Chaika
K.V. Chaika
OTO.A. Taran
O.A. Taran
HIH.O. Ivanova
H.O. Ivanova
SKS.O. Kachula
S.O. Kachula
Stress urinary incontinence negatively affects quality of life, social activity, and sexual health in women. In this context, the improvement of sexual function is a crucial indicator of treatment efficacy for urinary incontinence in this patient population. Aim - to analyze sexual function as a key component of the clinical effectiveness of sling surgery in women with stress urinary incontinence. Materials and methods. A comparative study of sexual function after sling surgical procedures for the correction of stress urinary incontinence was conducted in women under 50 years of age in two representative subgroups: IA (n=28) underwent free synthetic sling placement (TVT), and IB (n=30) underwent TVT-O combined with postoperative vaginal laser therapy. Women aged 50 and older were also divided into two subgroups: IIA (n=14) underwent TVT; IIB (n=10) underwent TVT-O followed by a postoperative course of promestriene (natural and semi-synthetic estrogens). Statistical analysis was performed using the SPSS 21 software package. Results. Vaginal laser therapy after TVT-O sling implantation significantly improved sexual function in a greater number of patients under 50 years of age compared to the corresponding comparison group. Vaginal promestriene therapy after TVT-O did not significantly affect the quality of sexual life in women aged 50 and older. Conclusions. Sexual function is an important component in evaluating the effectiveness of sling surgical intervention in women with stress urinary incontinence. Differentiated assessment of clinical manifestations of sexual dysfunction using specialized questionnaires allows identification of potential directions for their correction during further treatment. The research was carried out in accordance with the principles of the Helsinki Declaration. The study protocol was approved by the Local Ethics Committee of participating institution. Informed consent was obtained from all patients. The authors declare no conflict of interest.

28 October 2024 in Modern pediatrics. Ukraine
Verified
Journal Article
Open access
PDF file
MKM.I. Kravtsiv
M.I. Kravtsiv
ALA.M. Lisovska
A.M. Lisovska
VDV.M. Dudchenko
V.M. Dudchenko
VSV.A. Shamrai
V.A. Shamrai
ОTО.а. Taran
О.а. Taran
SKS.O. Kachula
S.O. Kachula
For the treatment of rheumatological diseases, autoimmune lymphoproliferative syndrome and nephrotic syndrome in children, glucocorticosteroid therapy with/without cytostatics is used. Immunosuppression is a serious side effect of these medications. Aim - to investigate immunological parameters in children receiving immunosuppressive therapy in order to determine vaccination tactics. Materials and methods. 50 healthy children (comparison group) and 34 children who received immunosuppressive therapy for rheumatological pathology, autoimmune lymphoproliferative syndrome or nephrotic syndrome (study group) participated in the study. Patients who received high-dose immunosuppressive therapy (n=16) made up the subgroup I, low-dose immunosuppressive therapy (n=18) - the subgroup II. Determination of subpopulations of blood lymphocytes was carried out by the method of flow cytometry, serum immunoglobulins - by the method of radial immunodiffusion. Statistical analysis was performed using the SPSS 23.0 software package. Results. In children who received immunosuppressive therapy, a significant increase in the number of T-lymphocytes (CD3+), a decrease in B-lymphocytes (CD19+) and NK cells (CD3-CD16/56+) was established, while the average levels of serum IgA, IgM, IgG did not differ from the indicators of healthy children, which demonstrates the preservation of humoral immunity. However, in children who received high-dose immunosuppressive therapy, a dose-dependent decrease in the level of serum IgA, IgM, and IgG was found, respectively, by 1.7, 1.3 times, and by 18.9%. Conclusions. It is advisable to vaccinate children before starting immunosuppressive therapy for rheumatological pathology or nephrotic syndrome. The research was carried out in accordance with the principles of the Helsinki Declaration. The study protocol was approved by the Local Ethics Committee of all participating institutions. The informed consent of the patient was obtained for conducting the studies. No conflict of interests was declared by the authors.

28 June 2026 in UKRAINIAN JOURNAL OF PERINATOLOGY AND PEDIATRICS
Verified
Journal Article
Open access
PDF file
RBR.M. Banakhevych
R.M. Banakhevych
TVT.V. Vasylenko
T.V. Vasylenko
IKI.V. Kuzhevsky
I.V. Kuzhevsky
DAD.I. Avierin
D.I. Avierin
VSV.A. Shamrai
V.A. Shamrai
SKS.O. Kachula
S.O. Kachula
High-grade serous ovarian carcinoma diagnosed during pregnancy or shortly after childbirth is a rare clinical situation. Nonspecific abdominal symptoms may be mistakenly interpreted as manifestations of pregnancy or postpartum recovery. Aim - to describe and analyze the rationale for and outcomes of neoadjuvant therapy followed by interval cytoreductive surgery in the treatment of advanced high-grade serous ovarian carcinoma diagnosed approximately three months after childbirth. Clinical case. A clinical case of treatment of a 39-year-old patient with advanced high-grade serous ovarian carcinoma diagnosed after delivery and a high peritoneal cancer index (PCI > 20) is described. The features of this case include the early postpartum manifestation of advanced ovarian cancer, a high peritoneal cancer index, the presence of sequential morphological material before and after neoadjuvant polychemotherapy, and the detection of a pathogenic mutation in the BRCA1 gene. The outcomes of neoadjuvant chemotherapy and interval cytoreductive surgery are discussed. Conclusions. Performing diagnostic laparoscopy enabled verification of the oncological process, determination of its molecular profile, and, given the advanced disease and a high peritoneal cancer index (PCI>20), selection of neoadjuvant therapy followed by interval cytoreductive surgery. Sequential histopathological assessment confirmed a partial response with residual viable tumor, while the detection of a somatic BRCA1 mutation substantiated the appropriateness of maintenance therapy with a poly(ADP-ribose) polymerase inhibitor and the need for germline testing. Persistent or progressive abdominal symptoms in the postpartum period require timely diagnostic imaging and a high level of oncological vigilance. The study was conducted in accordance with the principles of the Declaration of Helsinki. Written informed consent for treatment and publication of this case was obtained from the patient. No conflict of interests was declared by the authors.